146 related articles for article (PubMed ID: 38375454)
21. Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors.
Yang S; Tang Z; Hu C; Zhang D; Shen N; Yu H; Chen X
Adv Mater; 2019 Mar; 31(11):e1805955. PubMed ID: 30680816
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
23. Loss of inducible nitric oxide synthase expression in the mouse renal cell carcinoma cell line RENCA is mediated by microRNA miR-146a.
Perske C; Lahat N; Sheffy Levin S; Bitterman H; Hemmerlein B; Rahat MA
Am J Pathol; 2010 Oct; 177(4):2046-54. PubMed ID: 20709800
[TBL] [Abstract][Full Text] [Related]
24. Nanoparticles Composed of PEGylated Alternating Copolymer-Combretastatin A4 Conjugate for Cancer Therapy.
Zhang Y; Liu X; Wang X; He P; Xiao C; Yu H; Chen X
Macromol Biosci; 2021 Aug; 21(8):e2100077. PubMed ID: 34031970
[TBL] [Abstract][Full Text] [Related]
25. Reverse micelles-in-microspheres with sustained release of water-soluble combretastatin A4 phosphate for S180 tumor treatment.
Wu L; Qiu L
J Mater Chem B; 2016 Jan; 4(4):760-767. PubMed ID: 32262957
[TBL] [Abstract][Full Text] [Related]
26. A Chimeric Cetuximab-Functionalized Corona as a Potent Delivery System for Microtubule-Destabilizing Nanocomplexes to Hepatocellular Carcinoma Cells: A Focus on EGFR and Tubulin Intracellular Dynamics.
Poojari R; Kini S; Srivastava R; Panda D
Mol Pharm; 2015 Nov; 12(11):3908-23. PubMed ID: 26426829
[TBL] [Abstract][Full Text] [Related]
27. Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously.
Jiang J; Shen N; Song W; Yu H; Sakurai K; Tang Z; Li G
Biomater Sci; 2019 Dec; 7(12):5283-5291. PubMed ID: 31603448
[TBL] [Abstract][Full Text] [Related]
28. Tumor Microenvironment Remodeling-Mediated Sequential Drug Delivery Potentiates Treatment Efficacy.
Xu Y; Lv J; Liu F; Wang J; Liu Y; Kong C; Li Y; Shen N; Gu Z; Tang Z; Chen X
Adv Mater; 2024 Jun; 36(23):e2312493. PubMed ID: 38444177
[TBL] [Abstract][Full Text] [Related]
29. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
30. Hindering the unlimited proliferation of tumor cells synergizes with destroying tumor blood vessels for effective cancer treatment.
Liu Y; Xu Y; Wang Y; Lv J; Wang K; Tang Z
Biomater Sci; 2024 Feb; 12(5):1294-1306. PubMed ID: 38258411
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
[TBL] [Abstract][Full Text] [Related]
32. Block Copolymer Based Nanoparticles for Theranostic Intervention of Cervical Cancer: Synthesis, Pharmacokinetics, and in Vitro/in Vivo Evaluation in HeLa Xenograft Models.
Dumoga S; Rai Y; Bhatt AN; Tiwari AK; Singh S; Mishra AK; Kakkar D
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22195-22211. PubMed ID: 28608677
[TBL] [Abstract][Full Text] [Related]
33. Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect.
Luo Q; Lin L; Huang Q; Duan Z; Gu L; Zhang H; Gu Z; Gong Q; Luo K
Acta Biomater; 2022 Apr; 143():320-332. PubMed ID: 35235863
[TBL] [Abstract][Full Text] [Related]
34. Polypeptides Micelles Composed of Methoxy-Poly(Ethylene Glycol)-Poly(l-Glutamic Acid)-Poly(l-Phenylalanine) Triblock Polymer for Sustained Drug Delivery.
Liu X; Fan R; Lu B; Le Y
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30428623
[TBL] [Abstract][Full Text] [Related]
35. Compound C Inhibits Renca Renal Epithelial Carcinoma Growth in Syngeneic Mouse Models by Blocking Cell Cycle Progression, Adhesion and Invasion.
Lee M; Ham NY; Hwang CY; Jang J; Lee B; Jeong JW; Kang I; Yeo EJ
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077072
[TBL] [Abstract][Full Text] [Related]
36. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
37. Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophages.
Fan K; Zhou M; Pathak MK; Lindner DJ; Altuntas CZ; Tuohy VK; Borden EC; Yi T
J Immunol; 2005 Nov; 175(10):7003-8. PubMed ID: 16272361
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment with tadalafil attenuates cardiotoxicity induced by combretastatin A4 disodium phosphate in rats.
Nagashima Y; Tochinai R; Sekizawa SI; Kato D; Nakagawa T; Tsuru Y; Tatewaki Y; Mutoh T; Taki Y; Kuwahara M
J Toxicol Pathol; 2023 Jul; 36(3):151-158. PubMed ID: 37577366
[TBL] [Abstract][Full Text] [Related]
39. Dodecanol-poly(D,L-lactic acid)-b-poly (ethylene glycol)-folate (Dol-PLA-PEG-FA) nanoparticles: evaluation of cell cytotoxicity and selecting capability in vitro.
Wang S; Luo Y; Zeng S; Luo C; Yang L; Liang Z; Wang Y
Colloids Surf B Biointerfaces; 2013 Feb; 102():130-5. PubMed ID: 23000678
[TBL] [Abstract][Full Text] [Related]
40. Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma.
Zhang C; An T; Wang D; Wan G; Zhang M; Wang H; Zhang S; Li R; Yang X; Wang Y
J Control Release; 2016 Mar; 226():193-204. PubMed ID: 26896737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
